Dengue Inpatient/Outpatient Dosing Study (CIR 332)
Outpatient study with a 3 night inpatient stay enrolling adults 18-55 years old.
The purpose of this trial is to study a medication to prevent dengue virus infection. We want to see if the medication will prevent you from becoming infected with Dengue virus. In the future, we hope the medication will be used in travelers to help prevent them from getting dengue virus. The study (is):
-
3 months long
-
2-3 screening visits (about 2-3 hours each)
-
1 three-night inpatient stay*
-
1 dengue exposure visit (about 2-3 hours)
-
16 outpatient visits
-
1 full-day outpatient visit (12 hours)
Screening Date
December 6, 2023
December 12, 2023
December 15, 2023
December 18, 2023
January 2, 2024
Screening Location
CIR at Bayview Medical Campus
301 Building, 4th floor
301 Mason Lord Drive
Baltimore, MD 21224
Study Period
3 months
Compensation
up to $3850